POMC and heart failure: Importantly, TCH was associated with significantly less asymptomatic cardiotoxicity (> 10% decline in EF 9.4 vs. 18.6%; p < 0.001) and a lower incidence of symptomatic heart failure (0.4 vs. 2%; p < 0.001) than ACTH [8].